JOSHUA STORM: Open Payments
NPI 1962865139 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,813 in 139 payments from 16 companies in 2025. Trend: 2023 $2,434 · 2024 $2,211 · 2025 $2,813
Food & beverage: $2,813
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $577 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $512 |
| Janssen Biotech, Inc. | 18 | $375 |
| QOL Medical, LLC | 8 | $219 |
| GENZYME CORPORATION | 7 | $206 |
| PFIZER INC. | 8 | $163 |
| Ardelyx, Inc. | 9 | $152 |
| Lilly USA, LLC | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 4 | $99 |
| Ipsen Biopharmaceuticals, Inc | 4 | $95 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, Sucraid, DUPIXENT, RINVOQ, IBSRELA, EOHILIA.
Industry payments across VA — which companies pay providers there.
